2-(4-联苯基)-5-(4-叔丁基苯基)-1,3,4-恶二唑，CAS 登记号 15082-28-7，由济南圣和化工有限公司现货供应，可提供纯度 按批次COA提供(不公开发布) 的规格，下游主要用于有机化学品。支持样品与小批量试用，批量价格请联系我们获取，验收以批次 COA 为准。
有机化学品
每批随货提供 COA；可按需提供 MSDS 及技术文件。邮件注明产品名称与 CAS 号，一个工作日内回复报价。
本页已列出 2-(4-联苯基)-5-(4-叔丁基苯基)-1,3,4-恶二唑 的 CAS 号：15082-28-7，可与随货 COA 核对。
常见纯度为 按批次COA提供(不公开发布)，包装形式为 按订单/批次确认(不公开发布)，特殊规格可在询价时说明。
主要涉及有机化学品。
来信 info@591daili.com 或 WhatsApp 联系，提供产品名称、CAS 号与数量，确认价格与交期后即可安排发货，验收以批次 COA 为准。
2-(4-biphenylyl)-5-(4-tert-butylphenyl)-1,3,4-oxadiazole · CAS 15082-28-7 · C24H22N2O. UNII YKR9AP6LRZ.
| CAS Registry Number | 15082-28-7 |
|---|---|
| PubChem CID | 84782 |
| Molecular formula | C24H22N2O |
| IUPAC name | 2-(4-tert-butylphenyl)-5-(4-phenylphenyl)-1,3,4-oxadiazole |
| UNII (FDA) | YKR9AP6LRZ |
| Molecular Weight | 354.4 |
|---|---|
| XLogP3 | 6.4 |
| Hydrogen Bond Donor Count | 0 |
| Hydrogen Bond Acceptor Count | 3 |
| Rotatable Bond Count | 4 |
| Exact Mass | 354.173213330 |
| Monoisotopic Mass | 354.173213330 |
| Topological Polar Surface Area | 38.9 |
| Heavy Atom Count | 27 |
| Formal Charge | 0 |
| Reported hazard statements | H315 (100%), H319 (100%) |
|---|
H315 (100%): Causes skin irritation [Warning Skin corrosion/irritation]
H319 (100%): Causes serious eye irritation [Warning Serious eye damage/eye irritation]
15082-28-7; 2-(4-Biphenylyl)-5-(4-tert-butylphenyl)-1,3,4-oxadiazole; 1,3,4-Oxadiazole, 2-[1,1'-biphenyl]-4-yl-5-[4-(1,1-dimethylethyl)phenyl]-; 2-biphenyl-4-yl-5-(4-tert-butylphenyl)-1,3,4-oxadiazole; DTXSID5065851; 1,3,4-Oxadiazole, 2-(1,1'-biphenyl)-4-yl-5-(4-(1,1-dimethylethyl)phenyl)-; ButylPBD; RefChem:456824; DTXCID2034883; 2(4tertButylphenyl)5(4biphenylyl)1,3,4oxadiazole; 1,3,4Oxadiazole, 2(4biphenylyl)5(ptertbutylphenyl); 1,3,4Oxadiazole, 2(1,1'biphenyl)4yl5(4(1,1dimethylethyl)phenyl); 239-135-7; Butyl-PBD; butyl pbd; 2-(4-tert-Butylphenyl)-5-(4-biphenyl)-1,3,4-oxadiazole
CAS 15082-28-7; molecular formula C24H22N2O; molecular weight — g/mol.
15082-28-7, 2-(4-Biphenylyl)-5-(4-tert-butylphenyl)-1,3,4-oxadiazole, 1,3,4-Oxadiazole, 2-[1,1'-biphenyl]-4-yl-5-[4-(1,1-dimethylethyl)phenyl]-, 2-biphenyl-4-yl-5-(4-tert-butylphenyl)-1,3,4-oxadiazole, DTXSID5065851, 1,3,4-Oxadiazole, 2-(1,1'-biphenyl)-4-yl-5-(4-(1,1-dimethylethyl)phenyl)-.
Hazard statements reported: H315, H319.
Facts on this page are taken from PubChem (US National Library of Medicine) and Wikidata. Grade-specific data — assay, moisture, particle size, packaging, shelf life — is issued per batch on the COA and is not published here.